Live Breaking News & Updates on Teps Navb Us63937x2027

Stay updated with breaking news from Teps navb us63937x2027. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Navidea Biopharmaceuticals, Inc. Hires G2G Ventures as Executive Consultants; Chief Medical Officer Steps Down

Executive Consulting buttresses senior management’s focus on performance and targeted growth. Chief Medical Officer, Michael Rosol, Ph.D., steps down.
. | March 30, 2023 ....

United States , Alex Cappello , Navidea Manocept , Jason Myers , Michael Rosol , Stanford University School Of Medicine Molecular Pharmacology , Securities Exchange , Navidea Biopharmaceuticals Inc , Navidea Biopharmaceuticals , Executive Consultants , Chief Medical Officer , Stanford University School , Molecular Pharmacology , Securities Act , Securities Exchange Act , Annual Report , Nc Stock Exchange , Press Release , Teps Navb Us63937x2027 ,